Contemporary OB/GYN/LinkedIn
Jan 18, 2026, 07:48
DSMB Review Confirms Safety of Brexanolone for PPD – Contemporary OB/GYN
Contemporary OB/GYN shared a post on LinkedIn:
“A phase 3 trial of Lipocine Inc.‘s oral formulation of brexanolone, LPCN 1154, for postpartum depression, will continue without any modification following the completion of a second independent Data Safety Monitoring Board review.
In the second and last review, the DSMB found no safety concerns in the trial.
More details and more on the makeup of the trial.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 10, 2026, 16:11Abieyuwa Ehigiamusoe: Starting Your Embryology Journey?
-
Oct 10, 2026, 16:10Hajar Vahabzadeh: Embryo Quality – The Science Behind the Laboratory Environment
-
Oct 10, 2026, 16:08Karthik Raj: The POSEIDON Concept – Moving Beyond “Poor Responder”
-
Oct 10, 2026, 16:05Marking 15 Years of Fakih IVF Fertility Center
-
Oct 10, 2026, 16:04Eleni Polychronidou: How Men Feel About Infertility
-
Oct 10, 2026, 16:01Philippos Edimiris: Comparing Programmed Ovulatory FET with Modified Natural Cycle FET
-
Oct 10, 2026, 15:57Baby Caleb and His Mom Made the Day – Caperton Fertility Institute
-
Oct 10, 2026, 15:53Marga Esbert Algam: A Constructive and Engaging Visit to the Reproductive Medicine Laboratory and Cryobank
-
Oct 10, 2026, 15:50Why Mental Health Matters on the Fertility Journey – Egg Donor and Surrogate Solutions